Trial site
Mnogoprofilna Bolnitsa Za Aktivno Lechenie Puls AD
- 20running trials
- 13closed trials
The trials here
What the 33 trials at this site are about, from their registry records.
- Conditions
- Epilepsy5 trials
- Heart failure4 trials
- Multiple sclerosis4 trials
- Stroke4 trials
- Atrial fibrillation3 trials
- COPD3 trials
- Asthma2 trials
- Chronic kidney disease2 trials
- Obesity2 trials
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 trial
- Coronary artery disease1 trial
- Endometriosis1 trial
- and 2 more
- Phase
- Phase 325 trials
- Phase 28 trials
- Status
- Completed13 trials
- Recruiting11 trials
- Active, not recruiting7 trials
- Not yet recruiting2 trials
- Lead sponsor
- Immunic AG3 trials
- Xenon Pharmaceuticals Inc.3 trials
- Arrowhead Pharmaceuticals2 trials
- Chiesi Farmaceutici S.p.A.2 trials
- Janssen Research & Development, LLC2 trials
- and 19 more
Running trials
Recruiting
Not yet recruiting
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Recruiting
SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults with Focal Onset Seizures
Recruiting
Recruiting
Active, not recruiting
A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis
Active, not recruiting
Recruiting
Efepoetin alfa for treatment of anemia in chronic kidney disease on dialysis
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Enrolling by invitation
Recruiting
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Epilepsy3 recruiting
- Heart failure3 recruiting
- Multiple sclerosis3 recruiting
- Stroke2 recruiting
- Atrial fibrillation1 recruiting
- Chronic kidney disease1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Study of Plozasiran (ARO-APOC3) in Adults With Severe Hypertriglyceridemia
Active, not recruiting
Completed
Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia
Completed
A proof of concept and dose-finding study of XXB750 in patients with heart failure
Completed
Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-1
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Active, not recruiting
Completed
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
Completed
Completed
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures
Active, not recruiting
A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
Completed
The efficacy and safety of two doses of CHF6001 DPI as add-on to maintenance COPD triple therapy
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 19 Nov 2026